OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain
- PMID: 10817708
- PMCID: PMC89912
- DOI: 10.1128/AAC.44.6.1556-1561.2000
OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain
Erratum in
- Antimicrob Agents Chemother. 2006 Jun;50(6):2280
Abstract
Acinetobacter baumannii RYC 52763/97, a clinical isolate involved in a prolonged nosocomial outbreak at our hospital, was resistant to all beta-lactams tested, including imipenem and meropenem, which had MICs of 128 and 256 microg/ml, respectively. This strain synthesized three beta-lactamases: a plasmid-mediated TEM-1 beta-lactamase (pI 5.4), an AmpC-type chromosomal cephalosporinase (pI 9.4), and a novel, presumptively chromosomally mediated OXA-related enzyme (pI 9.0) named OXA-24. After cloning and sequencing, the deduced amino acid sequence of the OXA-24 beta-lactamase showed 40% homology with the OXA-10 (PSE-2) and OXA-7 beta-lactamases, 39% homology with the OXA-11 and OXA-5 enzymes, and 33% homology with the LCR-1 beta-lactamase. The amino acid sequence of the OXA-24 beta-lactamase contained the STFK motif found in serine beta-lactamases, but the typical class D triad KTG was replaced by KSG and the motif YGN was replaced by FGN. The OXA-24 beta-lactamase hydrolyzed benzylpenicillin and cephaloridine but lacked activity against oxacillin, cloxacillin, and methicillin. The enzymatic activity was inhibited by chloride ions and by tazobactam (50% inhibitory concentration [IC(50)], 0.5 microM), sulbactam (IC(50), 40 microM), and clavulanic acid (IC(50), 50 microM). Carbapenem MICs for an Escherichia coli transformant (pBMB-1) expressing the cloned OXA-24 enzyme had a fourfold increase. Relative V(max)/K(m) values of 13 and 6 were obtained with imipenem and meropenem, respectively, and a positive microbiological assay result with imipenem was obtained with a purified enzymatic extract of this transformant strain. Therefore, we consider this new beta-lactamase to be involved in the carbapenem resistance of A. baumannii RYC 52763/97.
Figures
References
-
- Afzal M S, Livermore D. Worldwide emergence of carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother. 1998;41:576–577. - PubMed
-
- Ambler R P. The structure of β-lactamases. Philos Trans R Soc Lond Biol Sci. 1980;289:321–331. - PubMed
-
- Amyes S G B, Young H-K. Mechanism of antibiotic resistance in Acinetobacter spp.—genetics of resistance. In: Bergogne-Berezin E, Joly-Guillou M L, Towner K J, editors. Acinetobacter: microbiology, epidemiology, infections, management, 1996. New York, N.Y: CRC Press; 1996. pp. 185–223.
-
- Bergogne-Bérézin E. Resistance of Acinetobacter spp. to antimicrobials—overview of clinical resistance patterns and therapeutic problems. In: Bergogne-Berezin E, Joly-Guillou M L, Towner K J, editors. Acinetobacter: microbiology, epidemiology, infections, management, 1996. New York, N.Y: CRC Press; 1996. pp. 133–183.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
